
Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy
Author(s) -
Tatsuhiko Sato,
Shinichi Morita,
Hideaki Bando,
Shigeru Satō,
Toshihide Ikeda,
Kazuyuki Emi
Publication year - 2013
Publication title -
middle east african journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.357
H-Index - 25
eISSN - 0975-1599
pISSN - 0974-9233
DOI - 10.4103/0974-9233.106387
Subject(s) - medicine , vitrectomy , bevacizumab , vitreous hemorrhage , diabetic retinopathy , ophthalmology , visual acuity , incidence (geometry) , surgery , retinal detachment , retinal , diabetes mellitus , chemotherapy , physics , optics , endocrinology
To evaluate the effect of preoperative intravitreal bevacizumab (IVB) on surgical procedures, visual prognosis, and postoperative complications, especially postoperative vitreous hemorrhage, in cases with proliferative diabetic retinopathy (PDR).